Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00791284 | A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function | PHASE1 | COMPLETED | 20 | — | — | Aug 1, 2004 | Dec 1, 2004 | Jun 8, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| Intermediate release (IR) Paliperidone | DRUG | - |
Inclusion Criteria: * Patients with normal hepatic function:Normotensive at screening, with supine (5 minutes) blood pressure between the range of 95 to 160 mmHg systolic, inclusive, and 55 to 95 mmHg diastolic, inclusive, demographically comparable to the hepatic impairment group with respect to a...